MetaADEDB 2.0 @ LMMD
Mesalamine
(KBOPZPXVLCULAV-UHFFFAOYSA-N)
Structure
SMILES
Nc1ccc(c(c1)C(=O)O)O
Type(s)
Approved
ATC code(s)
A07EC02
Molecular Formula:
C7H7NO3
Molecular Weight:
153.135
Log P:
1.2538
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
3
TPSA:
83.55
CAS Number(s):
89-57-6
Synonym(s)
1.
Mesalamine
External Link(s)
PubChem Compound4075
BindingDB60918
ChEBI6775
CHEMBLCHEMBL704
DrugBankDB00244
DrugCentral1710
IUPHAR/BPS Guide to PHARMACOLOGY2700
KEGGcpd:C07138
dr:D00377
Therapeutic Target DatabaseD0C4YC
ZINC1688
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 324
Canada Vigilance: 154
Canada Vigilance
SIDER
US FAERS
2Product use issueFAERS: 224US FAERS
3No adverse eventFAERS: 188US FAERS
4Medication residue presentFAERS: 164SIDER
US FAERS
5Inappropriate schedule of drug administrationFAERS: 142US FAERS
6Abdominal PainFAERS: 107
Canada Vigilance: 16
11860403CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
7Drug dose omissionFAERS: 106OFFSIDES
US FAERS
8HeadacheFAERS: 105
Canada Vigilance: 8
11593133
12834704
20871406
CTD
SIDER
Canada Vigilance
US FAERS
9NauseaFAERS: 98
Canada Vigilance: 9
11860403
18711101
CTD
SIDER
Canada Vigilance
US FAERS
10AlopeciaFAERS: 88
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
11MalaiseFAERS: 88
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
12PancreatitisFAERS: 75
Canada Vigilance: 11
12235076CTD
SIDER
Canada Vigilance
US FAERS
13PainFAERS: 72
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
14Product quality issueFAERS: 66US FAERS
15ChromaturiaFAERS: 65
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
16MyocarditisFAERS: 64
Canada Vigilance: 5

View details

CTD
SIDER
Canada Vigilance
US FAERS
17FatigueFAERS: 61
Canada Vigilance: 2
17404867
18711101
CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
18HypersensitivityFAERS: 59
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
19ArthralgiaFAERS: 58
Canada Vigilance: 5
15877665CTD
SIDER
Canada Vigilance
US FAERS
20Drug administered to patient of inappropriate ageFAERS: 56US FAERS
21Adverse eventFAERS: 55
Canada Vigilance: 1
Canada Vigilance
US FAERS
22VomitingFAERS: 53
Canada Vigilance: 6
17404867CTD
SIDER
Canada Vigilance
US FAERS
23Chest PainFAERS: 4810833545
18666333
CTD
SIDER
US FAERS
24ColitisFAERS: 44
Canada Vigilance: 4
25729217CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
25DizzinessFAERS: 44
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
26Weight decreasedFAERS: 42
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
27PericarditisFAERS: 41
Canada Vigilance: 2

View details

CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
28Abdominal discomfortFAERS: 40OFFSIDES
SIDER
US FAERS
29FlatulenceFAERS: 39
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
30Wrong technique in product usage processFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
31Incorrect dose administeredFAERS: 35OFFSIDES
US FAERS
32Eosinophilic PneumoniaFAERS: 33
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
33PneumoniaFAERS: 32
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
34AstheniaFAERS: 31
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
35Back PainFAERS: 30
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
36DehydrationFAERS: 30
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
37PruritusFAERS: 28
Canada Vigilance: 3
11906377CTD
SIDER
Canada Vigilance
US FAERS
38Unevaluable eventFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
39MyalgiaFAERS: 26
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
40Pericardial effusionFAERS: 268298382
10189017
CTD
OFFSIDES
SIDER
US FAERS
41ConstipationFAERS: 2520178728CTD
SIDER
US FAERS
42Inability to afford medicationFAERS: 25US FAERS
43UrticariaFAERS: 25
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
44EosinophiliaFAERS: 2210213581
15877665
18430794
CTD
SIDER
US FAERS
45PneumonitisFAERS: 22US FAERS
46Feeling abnormalFAERS: 20SIDER
US FAERS
47PleurisyFAERS: 20SIDER
US FAERS
48Cerebrovascular accidentFAERS: 19US FAERS
49Expired product administeredFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
50Maternal exposure during pregnancyFAERS: 19US FAERS
51Drug exposure during pregnancyFAERS: 18US FAERS
52DyspepsiaFAERS: 1811860403CTD
SIDER
US FAERS
53General physical health deteriorationFAERS: 18US FAERS
54Oral administration complicationFAERS: 18US FAERS
55Product substitution issueFAERS: 18US FAERS
56StressFAERS: 18US FAERS
57AnxietyFAERS: 17SIDER
US FAERS
58Clostridium difficile infectionFAERS: 17US FAERS
59ChillsFAERS: 16
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
60Inappropriate schedule of product administrationFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
61Product use in unapproved indicationFAERS: 16
Canada Vigilance: 4
Canada Vigilance
US FAERS
62Drug ineffective for unapproved indicationFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
63Drug prescribing errorFAERS: 15US FAERS
64InflammationFAERS: 1512924643
30365937
CTD
US FAERS
65Neck PainFAERS: 15
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
66TinnitusFAERS: 15
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
67Joint swellingFAERS: 14US FAERS
68Myocardial InfarctionFAERS: 14US FAERS
69Therapy cessationFAERS: 14US FAERS
70AcneFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
71PalpitationsFAERS: 13SIDER
US FAERS
72Product physical issueFAERS: 13US FAERS
73Product residue presentFAERS: 13
Canada Vigilance: 4
Canada Vigilance
US FAERS
74Disease recurrenceFAERS: 12OFFSIDES
US FAERS
75Prescribed overdoseFAERS: 12US FAERS
76Respiratory FailureFAERS: 12US FAERS
77ThrombocytopeniaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
78Toxicity to various agentsFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
79Blood creatinine increasedFAERS: 11
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
80Insurance issueFAERS: 11US FAERS
81Intentional product use issueFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
82Medication ErrorFAERS: 11US FAERS
83Oropharyngeal painFAERS: 11OFFSIDES
SIDER
US FAERS
84Product use complaintFAERS: 11US FAERS
85AsthmaFAERS: 10OFFSIDES
SIDER
US FAERS
86Atrial FibrillationFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
87HepatitisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
88NephrolithiasisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
89Nephrotic SyndromeFAERS: 103132281
9647514
CTD
SIDER
US FAERS
90OverdoseFAERS: 10
Canada Vigilance: 3
Canada Vigilance
US FAERS
91PancytopeniaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
92Product solubility abnormalFAERS: 10US FAERS
93Urinary tract infectionFAERS: 10SIDER
US FAERS
94jaundiceFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
95Intestinal ObstructionFAERS: 9OFFSIDES
SIDER
US FAERS
96NasopharyngitisFAERS: 9SIDER
US FAERS
97NervousnessFAERS: 9SIDER
US FAERS
98NeutropeniaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
99Peripheral swellingFAERS: 9US FAERS
100Rash erythematousFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
101ThrombosisFAERS: 9SIDER
US FAERS
102Transaminases increasedFAERS: 9SIDER
US FAERS
103AgranulocytosisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
104Blood glucose increasedFAERS: 8US FAERS
105Chest discomfortFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
106DiscomfortFAERS: 8SIDER
US FAERS
107Exposure during breast feedingFAERS: 8US FAERS
108LymphadenopathyFAERS: 8SIDER
US FAERS
109Night sweatsFAERS: 8US FAERS
110Pharmaceutical product complaintFAERS: 8US FAERS
111White blood cell count decreasedFAERS: 8US FAERS
112Alanine Aminotransferase IncreasedFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
113Blood alkaline phosphatase increasedFAERS: 7SIDER
US FAERS
114Blood urine presentFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
115CardiotoxicityFAERS: 7US FAERS
116Disease ProgressionFAERS: 7US FAERS
117Drug effect incompleteFAERS: 7US FAERS
118ErythemaFAERS: 711906377CTD
SIDER
US FAERS
119Gastrointestinal PainFAERS: 7SIDER
US FAERS
120InfluenzaFAERS: 7SIDER
US FAERS
121Lip swellingFAERS: 7US FAERS
122Medication residueFAERS: 7SIDER
US FAERS
123Memory impairmentFAERS: 7US FAERS
124Musculoskeletal stiffnessFAERS: 7SIDER
US FAERS
125MyopericarditisFAERS: 7US FAERS
126PregnancyFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
127Product difficult to swallowFAERS: 7US FAERS
128ProteinuriaFAERS: 717404867CTD
SIDER
US FAERS
129Rectal dischargeFAERS: 7SIDER
US FAERS
130SinusitisFAERS: 7OFFSIDES
SIDER
US FAERS
131SwellingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
132TremorFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
133AbasiaFAERS: 6OFFSIDES
US FAERS
134Aspartate Aminotransferase IncreasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
135Bowel movement irregularityFAERS: 6US FAERS
136Cardiac TamponadeFAERS: 6US FAERS
137Drug administration errorFAERS: 6US FAERS
138EpistaxisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
139HypophagiaFAERS: 6OFFSIDES
US FAERS
140Incorrect product storageFAERS: 6US FAERS
141MalnutritionFAERS: 6US FAERS
142Metabolic acidosisFAERS: 6OFFSIDES
US FAERS
143Product storage errorFAERS: 6US FAERS
144SyncopeFAERS: 6SIDER
US FAERS
145TachycardiaFAERS: 6SIDER
US FAERS
146VertigoFAERS: 6SIDER
US FAERS
147Wrong technique in drug usage processFAERS: 6OFFSIDES
US FAERS
148Acute Lung InjuryFAERS: 5US FAERS
149Blood creatine phosphokinase increasedFAERS: 5OFFSIDES
US FAERS
150Burning sensationFAERS: 5SIDER
US FAERS
151CholelithiasisFAERS: 5SIDER
US FAERS
152CryingFAERS: 5US FAERS
153DysuriaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
154EczemaFAERS: 5SIDER
US FAERS
155EructationFAERS: 5SIDER
US FAERS
156Gastrointestinal inflammationFAERS: 5OFFSIDES
US FAERS
157HypotensionFAERS: 5
Canada Vigilance: 1
9517663CTD
SIDER
Canada Vigilance
US FAERS
158InfectionFAERS: 5OFFSIDES
SIDER
US FAERS
159LeukopeniaFAERS: 5SIDER
US FAERS
160Lower respiratory tract infectionFAERS: 5US FAERS
161Lung consolidationFAERS: 5US FAERS
162OsteomyelitisFAERS: 5US FAERS
163Pleuritic painFAERS: 5US FAERS
164Post procedural complicationFAERS: 5US FAERS
165Product dose omissionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
166Product size issueFAERS: 5US FAERS
167Protein total decreasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
168Pulmonary FibrosisFAERS: 5US FAERS
169Pulmonary toxicityFAERS: 5US FAERS
170RestlessnessFAERS: 5US FAERS
171SomnolenceFAERS: 5SIDER
US FAERS
172StomatitisFAERS: 5
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
173Therapeutic response unexpectedFAERS: 5US FAERS
174Troponin increasedFAERS: 5US FAERS
175Visual ImpairmentFAERS: 5US FAERS
176muscle injuryFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
177treatment failureFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
178Accidental overdoseFAERS: 4US FAERS
179Activities of daily living impairedFAERS: 4US FAERS
180Acute kidney injuryFAERS: 4

View details

CTD
US FAERS
181Acute respiratory failureFAERS: 4OFFSIDES
US FAERS
182AmnesiaFAERS: 4US FAERS
183Anal FistulaFAERS: 4OFFSIDES
US FAERS
184Angina PectorisFAERS: 4SIDER
US FAERS
185ArthritisFAERS: 48298382CTD
SIDER
US FAERS
186Blood potassium decreasedFAERS: 4US FAERS
187Blood urea increasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
188Cardiac ArrestFAERS: 4US FAERS
189ChokingFAERS: 4US FAERS
190CholecystitisFAERS: 4SIDER
US FAERS
191DeafnessFAERS: 4SIDER
US FAERS
192DisabilityFAERS: 4US FAERS
193Drug toxicityFAERS: 4US FAERS
194Ejection Fraction DecreasedFAERS: 4US FAERS
195Emotional disorderFAERS: 4US FAERS
196HepatotoxicityFAERS: 4SIDER
US FAERS
197Incorrect drug administration durationFAERS: 4US FAERS
198Incorrect route of drug administrationFAERS: 4US FAERS
199Intentional product misuseFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
200Intestinal PerforationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
201Iron deficiencyFAERS: 4US FAERS
202JC virus infectionFAERS: 4US FAERS
203LethargyFAERS: 4SIDER
US FAERS
204Lupus-like syndromeFAERS: 4SIDER
US FAERS
205MalabsorptionFAERS: 4OFFSIDES
SIDER
US FAERS
206NephritisFAERS: 417168131CTD
SIDER
US FAERS
207PetechiaeFAERS: 4US FAERS
208Product availability issueFAERS: 4US FAERS
209Product formulation issueFAERS: 4US FAERS
210Product prescribing errorFAERS: 4US FAERS
211Product taste abnormalFAERS: 4US FAERS
212Productive CoughFAERS: 4US FAERS
213Pulmonary EosinophiliaFAERS: 4SIDER
US FAERS
214RegurgitationFAERS: 4US FAERS
215Sinus TachycardiaFAERS: 4SIDER
US FAERS
216VasculitisFAERS: 4US FAERS
217Ventricular hypokinesiaFAERS: 4US FAERS
218Abdominal tendernessFAERS: 3OFFSIDES
US FAERS
219AbscessFAERS: 3US FAERS
220Anal abscessFAERS: 3OFFSIDES
US FAERS
221Anorectal discomfortFAERS: 3SIDER
US FAERS
222ArthropathyFAERS: 3SIDER
US FAERS
223AtelectasisFAERS: 3OFFSIDES
US FAERS
224Atrioventricular BlockFAERS: 3US FAERS
225Autoimmune hepatitisFAERS: 3US FAERS
226CardiomegalyFAERS: 3US FAERS
227Cerebral InfarctionFAERS: 3US FAERS
228ColectomyFAERS: 3OFFSIDES
US FAERS
229Completed SuicideFAERS: 3US FAERS
230Depressed moodFAERS: 3US FAERS
231Diffuse alveolar damageFAERS: 3US FAERS
232DiplopiaFAERS: 3US FAERS
233DiverticulitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
234Drug withdrawal syndromeFAERS: 3US FAERS
235DysarthriaFAERS: 3US FAERS
236DysgeusiaFAERS: 3SIDER
US FAERS
237DysphoniaFAERS: 3US FAERS
238EndocarditisFAERS: 3US FAERS
239Epigastric discomfortFAERS: 3US FAERS
240Extranodal marginal zone B-cell lymphoma (MALT type)FAERS: 3US FAERS
241Facial paralysisFAERS: 3US FAERS
242Feeling ColdFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
243Flank PainFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
244Focal glomerulosclerosisFAERS: 3US FAERS
245Gastric ulcerFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
246Gastrointestinal sounds abnormalFAERS: 3US FAERS
247GoutFAERS: 3SIDER
US FAERS
248HypersomniaFAERS: 3US FAERS
249Impaired work abilityFAERS: 3US FAERS
250InfertilityFAERS: 3SIDER
US FAERS
251Intracranial AneurysmFAERS: 3US FAERS
252Large intestine perforationFAERS: 3US FAERS
253Lipase increasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
254Lymphocyte stimulation test positiveFAERS: 3US FAERS
255Maternal exposure timing unspecifiedFAERS: 3US FAERS
256MegacolonFAERS: 3US FAERS
257Multiple SclerosisFAERS: 3US FAERS
258Musculoskeletal PainFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
259Neuroleptic Malignant SyndromeFAERS: 3US FAERS
260Nonspecific reactionFAERS: 3US FAERS
261Pharyngolaryngeal PainFAERS: 3SIDER
US FAERS
262PleuropericarditisFAERS: 3OFFSIDES
SIDER
US FAERS
263PneumothoraxFAERS: 3US FAERS
264PresyncopeFAERS: 3US FAERS
265Product packaging quantity issueFAERS: 3US FAERS
266Product physical consistency issueFAERS: 3US FAERS
267PsoriasisFAERS: 3SIDER
US FAERS
268Pulmonary EmbolismFAERS: 3US FAERS
269Pulmonary granulomaFAERS: 3US FAERS
270PurpuraFAERS: 3US FAERS
271RalesFAERS: 3US FAERS
272Renal cystFAERS: 3US FAERS
273RetchingFAERS: 3US FAERS
274SepsisFAERS: 3US FAERS
275TachyarrhythmiaFAERS: 3US FAERS
276ToothacheFAERS: 3US FAERS
277Transmission of drug via semenFAERS: 3US FAERS
278Troponin I increasedFAERS: 3US FAERS
279WheezingFAERS: 3US FAERS
280furuncleFAERS: 3OFFSIDES
US FAERS
281Alopecia AreataFAERS: 2US FAERS
282AlveolitisFAERS: 2SIDER
US FAERS
283Anaphylactic shockFAERS: 2SIDER
US FAERS
284AngioedemaFAERS: 216454598CTD
SIDER
US FAERS
285AnorexiaFAERS: 2SIDER
US FAERS
286Antinuclear antibody increasedFAERS: 2US FAERS
287Apparent deathFAERS: 2US FAERS
288AppendicitisFAERS: 2OFFSIDES
US FAERS
289Application site painFAERS: 2US FAERS
290Autoimmune PancreatitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
291Back disorderFAERS: 2US FAERS
292Band neutrophil count increasedFAERS: 2US FAERS
293BedriddenFAERS: 2US FAERS
294Biopsy kidney abnormalFAERS: 2US FAERS
295Biopsy lung abnormalFAERS: 2US FAERS
296Biopsy skin abnormalFAERS: 2US FAERS
297Blood chloride decreasedFAERS: 2US FAERS
298Blood cholesterol abnormalFAERS: 2US FAERS
299Blood cholesterol increasedFAERS: 2US FAERS
300Blood count abnormalFAERS: 2US FAERS
301Blood creatinine abnormalFAERS: 2SIDER
US FAERS
302Blood iron decreasedFAERS: 2US FAERS
303Blood sodium decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
304BradycardiaFAERS: 29517663
16759561
CTD
US FAERS
305Breast FeedingFAERS: 2SIDER
US FAERS
306BronchiolitisFAERS: 2US FAERS
307BronchitisFAERS: 2OFFSIDES
SIDER
US FAERS
308Bronchoalveolar lavage abnormalFAERS: 2US FAERS
309Cardiac ventricular thrombosisFAERS: 2US FAERS
310Cerebellar infarctionFAERS: 2US FAERS
311CholestasisFAERS: 29059966CTD
SIDER
US FAERS
312Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
313Complications of maternal exposure to therapeutic drugsFAERS: 2US FAERS
314Contraindicated product administeredFAERS: 2US FAERS
315Diabetes MellitusFAERS: 2US FAERS
316Drug dispensing errorFAERS: 2US FAERS
317DysplasiaFAERS: 2US FAERS
318Ear discomfortFAERS: 2US FAERS
319Economic problemFAERS: 2US FAERS
320Electrocardiogram abnormalFAERS: 2US FAERS
321Eosinophilic pleural effusionFAERS: 2US FAERS
322Erectile dysfunctionFAERS: 2US FAERS
323Erythema NodosumFAERS: 2
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
324Febrile NeutropeniaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
325Gamma-Glutamyltransferase IncreasedFAERS: 2SIDER
US FAERS
326Gastrointestinal hypomotilityFAERS: 2US FAERS
327Hair metal test abnormalFAERS: 2US FAERS
328Head discomfortFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
329HepatomegalyFAERS: 2US FAERS
330HerniaFAERS: 2US FAERS
331HypokinesiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
332Ileal StenosisFAERS: 2US FAERS
333Inflammatory marker increasedFAERS: 2US FAERS
334Intercepted drug dispensing errorFAERS: 2US FAERS
335Irritable Bowel SyndromeFAERS: 2US FAERS
336Joint injuryFAERS: 2US FAERS
337Left atrial dilatationFAERS: 2US FAERS
338Leukocytoclastic vasculitisFAERS: 2US FAERS
339LeukocytosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
340Lip and/or oral cavity cancerFAERS: 2US FAERS
341Lung AbscessFAERS: 2US FAERS
342Lymphocyte percentage decreasedFAERS: 2US FAERS
343Lymphocytic infiltrationFAERS: 2US FAERS
344Malignant anorectal neoplasmFAERS: 2US FAERS
345Mental impairmentFAERS: 2US FAERS
346Metastatic NeoplasmFAERS: 2OFFSIDES
US FAERS
347Middle insomniaFAERS: 2US FAERS
348Mood swingsFAERS: 2SIDER
US FAERS
349Musculoskeletal discomfortFAERS: 2SIDER
US FAERS
350MyopathyFAERS: 2US FAERS
351MyositisFAERS: 2US FAERS
352Nephrogenic Diabetes InsipidusFAERS: 2US FAERS
353Neutrophil percentage decreasedFAERS: 2US FAERS
354OligohydramniosFAERS: 2US FAERS
355OnychoclasisFAERS: 2US FAERS
356PO2 decreasedFAERS: 2US FAERS
357Pancreatic enzymes increasedFAERS: 2US FAERS
358Peripheral motor neuropathyFAERS: 2US FAERS
359PeritonitisFAERS: 2US FAERS
360Pneumocystis jiroveci pneumoniaFAERS: 2US FAERS
361PolymyositisFAERS: 2US FAERS
362ProctitisFAERS: 2US FAERS
363Product coating issueFAERS: 2US FAERS
364Product expiration date issueFAERS: 2US FAERS
365Product label confusionFAERS: 2US FAERS
366Pulmonary vasculitisFAERS: 2US FAERS
367PyelonephritisFAERS: 211015014CTD
OFFSIDES
US FAERS
368Pyoderma GangrenosumFAERS: 2SIDER
US FAERS
369Rectal spasmFAERS: 2SIDER
US FAERS
370Rectal tenesmusFAERS: 2SIDER
US FAERS
371Renal ColicFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
372Restrictive pulmonary diseaseFAERS: 2US FAERS
373RhabdomyolysisFAERS: 2OFFSIDES
US FAERS
374RhinitisFAERS: 2SIDER
US FAERS
375Secretion dischargeFAERS: 2US FAERS
376Septic ShockFAERS: 2OFFSIDES
US FAERS
377Sexual DysfunctionFAERS: 2US FAERS
378Skin UlcerFAERS: 2US FAERS
379Skin lesionFAERS: 2US FAERS
380Systolic dysfunctionFAERS: 2US FAERS
381Therapeutic response changedFAERS: 2US FAERS
382Therapeutic response unexpected with drug substitutionFAERS: 2US FAERS
383ThirstFAERS: 2SIDER
US FAERS
384Throat cancerFAERS: 2US FAERS
385Throat irritationFAERS: 2US FAERS
386ToxocariasisFAERS: 2US FAERS
387UlcerFAERS: 2
Canada Vigilance: 1
24637189
25729217
CTD
Canada Vigilance
US FAERS
388Urinary RetentionFAERS: 2US FAERS
389Ventricular DysfunctionFAERS: 2US FAERS
390VitiligoFAERS: 2US FAERS
391White blood cell count abnormalFAERS: 2US FAERS
392pseudomembranous colitisFAERS: 2US FAERS
393Abdominal AbscessFAERS: 1US FAERS
394Abnormal weight gainFAERS: 1US FAERS
395Accidental exposure to productFAERS: 1US FAERS
396Acquired Immunodeficiency SyndromeFAERS: 1US FAERS
397Acquired von Willebrand's diseaseFAERS: 1US FAERS
398ActinomycosisFAERS: 1US FAERS
399Acute Coronary SyndromeFAERS: 1US FAERS
400Acute myocardial infarctionFAERS: 1US FAERS
401Acute prerenal failureFAERS: 1US FAERS
402Administration site irritationFAERS: 1US FAERS
403AgitationFAERS: 1US FAERS
404Albumin globulin ratio decreasedFAERS: 1US FAERS
405Alcohol IntoleranceFAERS: 1US FAERS
406Allergenic desensitisation procedureFAERS: 1US FAERS
407Allergic respiratory symptomFAERS: 1US FAERS
408Allergy to animalFAERS: 1US FAERS
409Amylase increasedFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
410Anal FissureFAERS: 1US FAERS
411Anal discomfortFAERS: 1SIDER
US FAERS
412AnencephalyFAERS: 1US FAERS
413AneurysmFAERS: 1US FAERS
414AngerFAERS: 1US FAERS
415Antibody test positiveFAERS: 1US FAERS
416Aortic AneurysmFAERS: 1US FAERS
417AortitisFAERS: 1US FAERS
418AphasiaFAERS: 1US FAERS
419Aphthous StomatitisFAERS: 1US FAERS
420AscitesFAERS: 1US FAERS
421AsphyxiaFAERS: 1US FAERS
422Aspiration pleural cavity abnormalFAERS: 1US FAERS
423AtaxiaFAERS: 1OFFSIDES
US FAERS
424Atrial FlutterFAERS: 1OFFSIDES
US FAERS
425Basal cell carcinomaFAERS: 1US FAERS
426Bile duct stent insertionFAERS: 1US FAERS
427Bilirubin conjugated increasedFAERS: 1US FAERS
428Biopsy bile duct abnormalFAERS: 1US FAERS
429Biopsy liver abnormalFAERS: 1US FAERS
430Bladder discomfortFAERS: 1US FAERS
431Blast cells presentFAERS: 1US FAERS
432BlepharospasmFAERS: 1US FAERS
433BlindnessFAERS: 1US FAERS
434Blood albumin abnormalFAERS: 1US FAERS
435Blood albumin decreasedFAERS: 1US FAERS
436Blood alkaline phosphatase decreasedFAERS: 1OFFSIDES
US FAERS
437Blood amylase increasedFAERS: 1US FAERS
438Blood cannabinoidsFAERS: 1US FAERS
439Blood chloride increasedFAERS: 1US FAERS
440Blood copper increasedFAERS: 1US FAERS
441Blood gases abnormalFAERS: 1US FAERS
442Blood iron increasedFAERS: 1US FAERS
443Blood lactate dehydrogenase increasedFAERS: 1SIDER
US FAERS
444Blood triglycerides increasedFAERS: 1US FAERS
445Blood urea abnormalFAERS: 1US FAERS
446Blood urea nitrogen/creatinine ratio decreasedFAERS: 1US FAERS
447Bone erosionFAERS: 1OFFSIDES
US FAERS
448Bone marrow eosinophilic leukocyte count increasedFAERS: 1US FAERS
449Bone painFAERS: 1OFFSIDES
US FAERS
450Brain natriuretic peptide increasedFAERS: 1US FAERS
451Breast cancer recurrentFAERS: 1US FAERS
452Breech PresentationFAERS: 1US FAERS
453Bronchial ObstructionFAERS: 1US FAERS
454Bronchial wall thickeningFAERS: 1US FAERS
455BronchiectasisFAERS: 1US FAERS
456BronchospasmFAERS: 1SIDER
US FAERS
457CachexiaFAERS: 1US FAERS
458CalcinosisFAERS: 1US FAERS
459Carbon dioxide decreasedFAERS: 1US FAERS
460CataractFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
461Cerebellar HypoplasiaFAERS: 1US FAERS
462Cerebral atrophyFAERS: 1US FAERS
463Cerebral ventricle dilatationFAERS: 1US FAERS
464Cervix carcinomaFAERS: 1US FAERS
465CholangitisFAERS: 1US FAERS
466Cleft PalateFAERS: 1US FAERS
467Clostridium colitisFAERS: 1US FAERS
468Clostridium difficile colitisFAERS: 1US FAERS
469Colonic fistulaFAERS: 1US FAERS
470Colonoscopy abnormalFAERS: 1US FAERS
471Complication associated with deviceFAERS: 1US FAERS
472Congenital HypothyroidismFAERS: 1US FAERS
473Contraindicated drug administeredFAERS: 1US FAERS
474Contraindicated drug prescribedFAERS: 1US FAERS
475Creatinine renal clearance decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
476CyanosisFAERS: 1US FAERS
477CystFAERS: 1US FAERS
478Cytomegalovirus test positiveFAERS: 1US FAERS
479CytopeniaFAERS: 1US FAERS
480Deafness NeurosensoryFAERS: 1US FAERS
481Deep Vein ThrombosisFAERS: 1US FAERS
482DeliriumFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
483DemyelinationFAERS: 1US FAERS
484Dental cariesFAERS: 1US FAERS
485Dentofacial anomalyFAERS: 1US FAERS
486DermatitisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
487DermatomyositisFAERS: 1US FAERS
488Device occlusionFAERS: 1US FAERS
489Diffuse alopeciaFAERS: 1US FAERS
490Disseminated Intravascular CoagulationFAERS: 1US FAERS
491Drug ToleranceFAERS: 1US FAERS
492Drug abuseFAERS: 1US FAERS
493Drug effect delayedFAERS: 1US FAERS
494Drug exposure via breast milkFAERS: 1US FAERS
495Drug monitoring procedure not performedFAERS: 1US FAERS
496Drug resistanceFAERS: 1US FAERS
497Dry skinFAERS: 1SIDER
US FAERS
498Ductus arteriosus premature closureFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
499Duodenal UlcerFAERS: 1SIDER
US FAERS
500DyscheziaFAERS: 1SIDER
US FAERS
501Echocardiogram abnormalFAERS: 1US FAERS
502Educational problemFAERS: 1US FAERS
503Ejection fraction abnormalFAERS: 1US FAERS
504Electrocardiogram T wave biphasicFAERS: 1US FAERS
505Electrolyte imbalanceFAERS: 1US FAERS
506Emotional distressFAERS: 1US FAERS
507Enzyme abnormalityFAERS: 1US FAERS
508Eosinophil percentage increasedFAERS: 1US FAERS
509Eosinophilic colitisFAERS: 1US FAERS
510Eosinophilic granulomatosis with polyangiitisFAERS: 1US FAERS
511Erythrodermic psoriasisFAERS: 1US FAERS
512Escherichia infectionFAERS: 1OFFSIDES
US FAERS
513Escherichia test positiveFAERS: 1US FAERS
514Expulsion of medicationFAERS: 1US FAERS
515Eye allergyFAERS: 1US FAERS
516Feeding tube complicationFAERS: 1US FAERS
517Feeding tube userFAERS: 1US FAERS
518Feeling jitteryFAERS: 1US FAERS
519Feeling of body temperature changeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
520FibromyalgiaFAERS: 1US FAERS
521FibrosisFAERS: 111205659CTD
US FAERS
522FlushingFAERS: 1US FAERS
523Focal Nodular HyperplasiaFAERS: 1US FAERS
524Food AllergyFAERS: 1US FAERS
525Food PoisoningFAERS: 1US FAERS
526Food cravingFAERS: 1US FAERS
527Foreign body in respiratory tractFAERS: 1US FAERS
528Foreign body traumaFAERS: 1US FAERS
529Foreign travelFAERS: 1US FAERS
530FormicationFAERS: 1US FAERS
531FractureFAERS: 1US FAERS
532Frustration tolerance decreasedFAERS: 1US FAERS
533FrustrationFAERS: 1US FAERS
534Full blood count abnormalFAERS: 1US FAERS
535Gait inabilityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
536Gastric hypomotilityFAERS: 1US FAERS
537Gastric mucosa erythemaFAERS: 1US FAERS
538GastritisFAERS: 1SIDER
US FAERS
539GastroenteritisFAERS: 1SIDER
US FAERS
540Gastrointestinal erosionFAERS: 1OFFSIDES
US FAERS
541Gastrointestinal infectionFAERS: 1OFFSIDES
US FAERS
542Gastrointestinal stenosisFAERS: 1US FAERS
543Gastrointestinal ulcerFAERS: 1US FAERS
544General physical condition abnormalFAERS: 1US FAERS
545General symptomFAERS: 1US FAERS
546Granulomatosis with polyangiitisFAERS: 1US FAERS
547GranulomaFAERS: 110406274CTD
OFFSIDES
US FAERS
548Guillain-Barre SyndromeFAERS: 1SIDER
US FAERS
549Hair growth rate abnormalFAERS: 1US FAERS
550Hair injuryFAERS: 1US FAERS
551Haptoglobin DecreasedFAERS: 1US FAERS
552HemiparesisFAERS: 1US FAERS
553HemiplegiaFAERS: 1US FAERS
554Hepatitis AFAERS: 1US FAERS
555Hepatitis BFAERS: 1US FAERS
556Hepatitis CFAERS: 1US FAERS
557Hilar lymphadenopathyFAERS: 1US FAERS
558HungerFAERS: 1US FAERS
559HydrocephalusFAERS: 1US FAERS
560HydropneumothoraxFAERS: 1US FAERS
561HyperacusisFAERS: 1US FAERS
562HypercreatininaemiaFAERS: 1US FAERS
563HyperkinesiaFAERS: 1US FAERS
564HyperplasiaFAERS: 1US FAERS
565Hypersensitivity myocarditisFAERS: 1US FAERS
566HypoxiaFAERS: 1US FAERS
567HysterectomyFAERS: 1US FAERS
568Idiopathic Pulmonary FibrosisFAERS: 1SIDER
US FAERS
569Idiosyncratic drug reactionFAERS: 1US FAERS
570IleitisFAERS: 1US FAERS
571IleusFAERS: 1US FAERS
572ImmobileFAERS: 1US FAERS
573Impaired gastric emptyingFAERS: 1US FAERS
574Inappropriate release of product for distributionFAERS: 1US FAERS
575IncontinenceFAERS: 1US FAERS
576Incorrect product administration durationFAERS: 1US FAERS
577Increased tendency to bruiseFAERS: 1US FAERS
578Infectious colitisFAERS: 1US FAERS
579Infrequent bowel movementsFAERS: 1US FAERS
580Intentional dose omissionFAERS: 1US FAERS
581Intentional drug misuseFAERS: 1US FAERS
582Intestinal FistulaFAERS: 1US FAERS
583Intestinal resectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
584Joint Range of Motion DecreasedFAERS: 1US FAERS
585Joint sprainFAERS: 1US FAERS
586Joint stiffnessFAERS: 1US FAERS
587Jugular vein distensionFAERS: 1US FAERS
588KetoacidosisFAERS: 1US FAERS
589Kounis SyndromeFAERS: 1US FAERS
590Lactose IntoleranceFAERS: 1US FAERS
591Limb discomfortFAERS: 1US FAERS
592Liver transplant rejectionFAERS: 1US FAERS
593Living in residential institutionFAERS: 1US FAERS
594Lower respiratory tract inflammationFAERS: 1US FAERS
595Lumbar puncture abnormalFAERS: 1US FAERS
596Lymphocyte count decreasedFAERS: 1OFFSIDES
US FAERS
597LymphomaFAERS: 1US FAERS
598LymphopeniaFAERS: 1US FAERS
599Macular degenerationFAERS: 1US FAERS
600MastoiditisFAERS: 1US FAERS
601MeaslesFAERS: 1US FAERS
602Medical dietFAERS: 1US FAERS
603MeningomyeloceleFAERS: 1US FAERS
604MenorrhagiaFAERS: 1SIDER
US FAERS
605MesotheliomaFAERS: 1US FAERS
606Metabolic alkalosisFAERS: 1US FAERS
607MicroalbuminuriaFAERS: 1US FAERS
608MultimorbidityFAERS: 1US FAERS
609Multiple MyelomaFAERS: 1US FAERS
610MumpsFAERS: 1US FAERS
611Muscle RigidityFAERS: 1US FAERS
612Muscle strainFAERS: 1US FAERS
613Muscle tightnessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
614Myasthenia GravisFAERS: 1OFFSIDES
US FAERS
615MydriasisFAERS: 1US FAERS
616MyelitisFAERS: 1SIDER
US FAERS
617Nephritic syndromeFAERS: 1US FAERS
618Nephritis allergicFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
619NephroangiosclerosisFAERS: 1US FAERS
620Nerve injuryFAERS: 1US FAERS
621NeuralgiaFAERS: 1US FAERS
622Neurosensory hypoacusisFAERS: 1US FAERS
623Neutropenic sepsisFAERS: 1US FAERS
624Neutrophil count decreasedFAERS: 1OFFSIDES
US FAERS
625Neutrophilic dermatosisFAERS: 1US FAERS
626Nicotine DependenceFAERS: 1US FAERS
627No reaction on previous exposure to drugFAERS: 1US FAERS
628Nodular regenerative hyperplasiaFAERS: 1US FAERS
629NoduleFAERS: 1US FAERS
630Non-cardiac chest painFAERS: 1US FAERS
631Nuclear magnetic resonance imaging thoracic abnormalFAERS: 1US FAERS
632Ocular icterusFAERS: 1US FAERS
633OliguriaFAERS: 1US FAERS
634OnychomycosisFAERS: 1US FAERS
635Oral painFAERS: 1US FAERS
636Oropharyngeal discomfortFAERS: 1SIDER
US FAERS
637OsteoporosisFAERS: 1US FAERS
638PallorFAERS: 1US FAERS
639PapuleFAERS: 1US FAERS
640ParesisFAERS: 1US FAERS
641Peptic UlcerFAERS: 1US FAERS
642Performance status decreasedFAERS: 1US FAERS
643Peripancreatic fluid collectionFAERS: 1US FAERS
644Peripheral embolismFAERS: 1OFFSIDES
US FAERS
645Personality ChangeFAERS: 1US FAERS
646PertussisFAERS: 1US FAERS
647PharyngitisFAERS: 1SIDER
US FAERS
648PhotodermatosisFAERS: 1US FAERS
649Platelet count abnormalFAERS: 1US FAERS
650Platelet function test abnormalFAERS: 1US FAERS
651PolydipsiaFAERS: 1US FAERS
652PolyuriaFAERS: 12224669
12003743
17404867
CTD
US FAERS
653Poor quality drug administeredFAERS: 1US FAERS
654Precancerous skin lesionFAERS: 1US FAERS
655Prescribed underdoseFAERS: 1US FAERS
656Procalcitonin increasedFAERS: 1US FAERS
657Procedural complicationFAERS: 1US FAERS
658Product contaminationFAERS: 1US FAERS
659Product dispensing errorFAERS: 1US FAERS
660Product label issueFAERS: 1US FAERS
661Product outer packaging issueFAERS: 1US FAERS
662Product packaging issueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
663Product prescribing issueFAERS: 1US FAERS
664Product shape issueFAERS: 1US FAERS
665Product supply issueFAERS: 1US FAERS
666Product tamperingFAERS: 1US FAERS
667Protein urine presentFAERS: 1SIDER
US FAERS
668Protein-losing gastroenteropathyFAERS: 1US FAERS
669Pruritus AniFAERS: 1US FAERS
670Psychiatric symptomFAERS: 1US FAERS
671Pulmonary function challenge test abnormalFAERS: 1US FAERS
672Pulmonary function test decreasedFAERS: 1US FAERS
673PurulenceFAERS: 1US FAERS
674Pyloric StenosisFAERS: 1US FAERS
675QuadriplegiaFAERS: 1US FAERS
676Quality of life decreasedFAERS: 1US FAERS
677Rectal StenosisFAERS: 1US FAERS
678Rectal abscessFAERS: 1US FAERS
679Rectal fissureFAERS: 1US FAERS
680Rectal injuryFAERS: 1US FAERS
681Red blood cell schistocytes presentFAERS: 1US FAERS
682Reflux gastritisFAERS: 1US FAERS
683Renal Cell CarcinomaFAERS: 1US FAERS
684Renal massFAERS: 1US FAERS
685Renal painFAERS: 1US FAERS
686Renal tubular disorderFAERS: 1US FAERS
687Reticulocyte count increasedFAERS: 1US FAERS
688Retinal scarFAERS: 1US FAERS
689Rotator cuff syndromeFAERS: 1US FAERS
690SarcoidosisFAERS: 1US FAERS
691ScabFAERS: 1OFFSIDES
US FAERS
692SclerodactyliaFAERS: 1US FAERS
693Seizure like phenomenaFAERS: 1US FAERS
694Serum SicknessFAERS: 1US FAERS
695ShockFAERS: 1SIDER
US FAERS
696Shoulder PainFAERS: 1US FAERS
697SigmoiditisFAERS: 1OFFSIDES
US FAERS
698Single functional kidneyFAERS: 1US FAERS
699Skin IndurationFAERS: 1US FAERS
700Skin hypertrophyFAERS: 1US FAERS
701Skin reactionFAERS: 1US FAERS
702Skin test positiveFAERS: 1US FAERS
703SneezingFAERS: 1US FAERS
704Soft tissue massFAERS: 1US FAERS
705Spermatozoa abnormalFAERS: 1US FAERS
706StaringFAERS: 1US FAERS
707Stevens-Johnson SyndromeFAERS: 1SIDER
US FAERS
708Stoma creationFAERS: 1US FAERS
709Stool analysis abnormalFAERS: 1US FAERS
710Streptococcal urinary tract infectionFAERS: 1US FAERS
711Suicide attemptFAERS: 1US FAERS
712SunburnFAERS: 1US FAERS
713Symptom recurrenceFAERS: 1US FAERS
714SyndactylyFAERS: 1US FAERS
715TalipesFAERS: 1US FAERS
716Tardive DyskinesiaFAERS: 1US FAERS
717Temperature intoleranceFAERS: 1US FAERS
718Therapeutic product effect variableFAERS: 1US FAERS
719Therapeutic product ineffectiveFAERS: 1US FAERS
720Therapy changeFAERS: 1US FAERS
721Therapy non-responderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
722Therapy regimen changedFAERS: 1US FAERS
723Thrombocytopenic purpuraFAERS: 1US FAERS
724ThrombocytosisFAERS: 1SIDER
US FAERS
725TonsillitisFAERS: 1US FAERS
726TrichorrhexisFAERS: 1US FAERS
727Troponin T increasedFAERS: 1US FAERS
728Urinary IncontinenceFAERS: 1US FAERS
729Urinary sediment presentFAERS: 1US FAERS
730Urticaria localisedFAERS: 1US FAERS
731UveitisFAERS: 1US FAERS
732VIIth nerve paralysisFAERS: 1US FAERS
733Vaginal DischargeFAERS: 1US FAERS
734Vascular stenosisFAERS: 1US FAERS
735Vascular stent thrombosisFAERS: 1US FAERS
736Ventricular FibrillationFAERS: 1US FAERS
737Viral myocarditisFAERS: 1US FAERS
738Viral upper respiratory tract infectionFAERS: 1US FAERS
739Vulvovaginal burning sensationFAERS: 1US FAERS
740Vulvovaginal discomfortFAERS: 1US FAERS
741Vulvovaginal swellingFAERS: 1US FAERS
742Wrong drug administeredFAERS: 1US FAERS
743nervous system disorderFAERS: 1SIDER
US FAERS
744Abdominal CrampsSIDER
745Abdominal InfectionOFFSIDES
746Abdominal adhesionsOFFSIDES
747Abdominal bloatingSIDER
748Abdominal wall infectionOFFSIDES
749Accidental exposureOFFSIDES
750Accidental needle stickOFFSIDES
751AcheSIDER
752Acidosis17404867CTD
753Acrodermatitis18711101CTD
754AdenitisOFFSIDES
755Administration site reactionSIDER
756AgoraphobiaOFFSIDES
757AlbuminuriaCanada Vigilance: 1Canada Vigilance
SIDER
758Allergic exanthemaSIDER
759Alopecia reversibleSIDER
760Amaurosis FugaxCanada Vigilance: 1Canada Vigilance
761AmblyopiaSIDER
762AmenorrheaOFFSIDES
763Antiphospholipid SyndromeOFFSIDES
764AnuriaOFFSIDES
765AppendectomyOFFSIDES
766Arterial bypass operationOFFSIDES
767AzoospermiaSIDER
768Back distressSIDER
769Bacterial Infections12669766CTD
770Bladder painSIDER
771Blood and lymphatic system disordersSIDER
772Blood blisterOFFSIDES
773Blood creatinine decreasedOFFSIDES
774Blood magnesium decreasedOFFSIDES
775Blood phosphorus decreasedOFFSIDES
776Blood potassium increasedCanada Vigilance: 1Canada Vigilance
OFFSIDES
777Blood pressure fluctuationOFFSIDES
778Bone fragmentationOFFSIDES
779Bone marrow depressionSIDER
780Breast MicrocalcificationOFFSIDES
781BronchopneumoniaOFFSIDES
782Carcinoma in situ of skinOFFSIDES
783Cardiac FlutterSIDER
784Celiac Disease20871406CTD
785CellulitisOFFSIDES
786Chemical and Drug Induced Liver Injury

View details

CTD
787Chronic interstitial nephritisSIDER
788Chronic ulcerative colitisOFFSIDES
789Clostridium difficile sepsisOFFSIDES
790Colonic Neoplasms1358165CTD
791Colorectal Neoplasms21115095CTD
792ConjunctivitisSIDER
793Cramps of lower extremitiesSIDER
794Crohn Disease

View details

CTD
795Crohns disease aggravatedSIDER
796CystitisSIDER
797Depressed Level of ConsciousnessCanada Vigilance: 1Canada Vigilance
798Device FailureOFFSIDES
799Device related infectionOFFSIDES
800Diarrhea11860403CTD
OFFSIDES
801Diastolic dysfunctionOFFSIDES
802Discomfort rectalSIDER
803DisorientationSIDER
804Disturbance in sexual arousalSIDER
805Drug Eruptions18711101CTD
806Drug delivery system malfunctionOFFSIDES
807Ear and labyrinth disordersSIDER
808Ear congestionSIDER
809EcchymosisSIDER
810Edema24637189
25729217
CTD
811Endodontic procedureOFFSIDES
812Enlargement abdomenSIDER
813EnteritisOFFSIDES
814EnteroceleOFFSIDES
815Enterococcal infectionOFFSIDES
816EnterocolitisOFFSIDES
817Enterocutaneous FistulaOFFSIDES
818EpididymitisSIDER
819Erythema MultiformeSIDER
820Essential TremorOFFSIDES
821Exacerbation of asthmaSIDER
822Eye laser surgeryOFFSIDES
823Eye painSIDER
824Fever8298382
10406274
15877665
CTD
825Fistula dischargeOFFSIDES
826Fixed eruptionOFFSIDES
827Gait Disorders, Neurologic12763355CTD
828GastroduodenitisOFFSIDES
829Hamman-Rich syndromeSIDER
830Head titubationOFFSIDES
831Hematuria9882028
17404867
CTD
832Hemorrhage25729217CTD
833Hepatic impairmentSIDER
834Hepatic necrosisSIDER
835Hepatic vein stenosisOFFSIDES
836HidradenitisOFFSIDES
837HirsutismSIDER
838Hyperosmolar stateOFFSIDES
839Incisional herniaOFFSIDES
840Increased insulin requirementCanada Vigilance: 1Canada Vigilance
841InfestationSIDER
842Inflammatory Bowel Diseases

View details

CTD
843Injection site erythemaOFFSIDES
844Injection site irritationOFFSIDES
845Injection site maculeOFFSIDES
846Injection site massOFFSIDES
847Injection site noduleOFFSIDES
848Injection site phlebitisOFFSIDES
849Injection site pruritusOFFSIDES
850Injection site urticariaOFFSIDES
851Injection site warmthOFFSIDES
852Intervertebral disc compressionOFFSIDES
853Intestinal Diseases16454598CTD
854Intraocular inflammationOFFSIDES
855Kidney Diseases

View details

CTD
856Kidney Failure, Chronic

View details

CTD
857Kidney Papillary Necrosis5128205CTD
858Lacrimal structural disorderSIDER
859Lactic dehydrogenase activity increasedSIDER
860Lichen PlanusSIDER
861Lip exfoliationOFFSIDES
862Lipoid nephrosisSIDER
863Liver AbscessOFFSIDES
864Liver Cirrhosis29738702CTD
865Local reactionSIDER
866Lupus ErythematosusSIDER
867MalocclusionOFFSIDES
868MastectomyOFFSIDES
869MeningiomaOFFSIDES
870MetrorrhagiaSIDER
871Mitral Valve Insufficiency16633055CTD
872Mucocutaneous Lymph Node Syndrome1992637CTD
873Muscle Weakness12763355CTD
874Muscular Atrophy12763355CTD
875Nail pigmentationOFFSIDES
876Nephritis, Interstitial

View details

CTD
877NeuropathySIDER
878Neutropenic infectionOFFSIDES
879NystagmusOFFSIDES
880Obsessive-Compulsive DisorderCanada Vigilance: 1Canada Vigilance
881OligospermiaSIDER
882Oral candidiasisSIDER
883Osteitis DeformansOFFSIDES
884PancolitisSIDER
885Pancreatic enlargementOFFSIDES
886Parotid duct obstructionOFFSIDES
887Pelvic abscessOFFSIDES
888Peptic Ulcer PerforationSIDER
889Poor dental conditionOFFSIDES
890Proctocolitis7830805
19212915
CTD
SIDER
891Product complaintCanada Vigilance: 1Canada Vigilance
892Product intoleranceCanada Vigilance: 1Canada Vigilance
893PrurigoSIDER
894Pseudomonal sepsisOFFSIDES
895Pseudotumor Cerebri11593133
12834704
CTD
896PyodermaSIDER
897Rectal crampsSIDER
898Rectal polypSIDER
899Reflex, Abnormal12763355CTD
900Renal Insufficiency11344635
15877665
17168131
CTD
901Renal tubular necrosisOFFSIDES
902Respiratory tract congestionOFFSIDES
903Rheumatoid ArthritisSIDER
904RhinorrheaOFFSIDES
905SacroiliitisOFFSIDES
906SclerodermaOFFSIDES
907ScotomaSIDER
908Serum Amylase IncreasedSIDER
909Skin Diseases, Vascular8298382CTD
910Skin irritationCanada Vigilance: 1Canada Vigilance
911Skin necrosisSIDER
912Small Intestinal StenosisOFFSIDES
913Sperm concentration decreasedSIDER
914Sperm count decreasedSIDER
915StiffnessSIDER
916Sudden deathCanada Vigilance: 1Canada Vigilance
917SweatingSIDER
918TensionSIDER
919Therapeutic product effect decreasedCanada Vigilance: 5Canada Vigilance
920Upset stomachSIDER
921Urinary tract infection enterococcalOFFSIDES
922Vascular insufficiencyOFFSIDES
923Vasodilation procedureSIDER
924VasodilationSIDER
925Vision Disorders12834704CTD
926Vitreous DetachmentOFFSIDES
927Vulvovaginal mycotic infectionSIDER
928Wound infection staphylococcalOFFSIDES
929anaphylaxis11906377CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.